NCT02862743View on ClinicalTrials.gov

Molecular Characterization of Advanced Stage Melanoma by Blood Sampling

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 14, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Metastatic Melanoma
Interventions
OTHER

patients with metastatic melanoma

Blood sample to realize molecular characterization of melanoma

Trial Locations (1)

51092

Chu de Reims, Reims

All Listed Sponsors
lead

CHU de Reims

OTHER

NCT02862743 - Molecular Characterization of Advanced Stage Melanoma by Blood Sampling | Biotech Hunter | Biotech Hunter